PMC:7441777 / 1879-2000
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T10 | 112-120 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T34 | 34-38 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
| T35 | 52-55 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 52 | 46-50 | Gene | denotes | TF2b | Gene:2959 |
| 53 | 68-72 | Gene | denotes | RdRp | Gene:43740578 |
| 74 | 34-38 | Chemical | denotes | EGCG | MESH:C045651 |
| 81 | 112-120 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 0-121 | Sentence | denotes | Overall, our results suggest that EGCG, TF2a, TF2b, TF3 can inhibit RdRp and represent an effective therapy for COVID-19. |